5,412,000,000 United States dollar
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2022-12-31
- Valid until
- still holds
- Published
- 2023-02-22
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
Sources
Cite this claim
Plain text
AsOf. "Gilead Sciences cash and equivalents: 5,412,000,000 United States dollar", as of 2022-12-31. Claim clm_7B68B20F3E17, https://asof.is/claim/clm_7B68B20F3E17, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209523000007/0000882095-23-000007-index.htm.
APA
AsOf. (2022). Gilead Sciences cash and equivalents: 5,412,000,000 United States dollar (as of 2022-12-31) [Record clm_7B68B20F3E17]. Retrieved November 9, 2026, from https://asof.is/claim/clm_7B68B20F3E17 (source: https://www.sec.gov/Archives/edgar/data/882095/000088209523000007/0000882095-23-000007-index.htm)
BibTeX
@misc{asof_clm_7B68B20F3E17,
author = {AsOf},
title = {Gilead Sciences cash and equivalents: 5,412,000,000 United States dollar},
year = {2022},
howpublished = {\url{https://asof.is/claim/clm_7B68B20F3E17}},
note = {Claim clm\_7B68B20F3E17, as of 2022-12-31; source: https://www.sec.gov/Archives/edgar/data/882095/000088209523000007/0000882095-23-000007-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_7B68B20F3E17.md/v1/claims/clm_7B68B20F3E17submit a correction